Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications-Reference-Cited by-同舟云学术

Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications

Published:2013-01-11 Issue:2 Volume:67 Page:170-180
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Bennie M.¹²,Bishop I.²,Godman B.³⁴⁵,Barbui C.⁶,Raschi E.⁷,Campbell S.⁸,Miranda J.⁹,Gustafsson L. L.³

Affiliation:

1. Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde; Glasgow UK

2. Information Services Division; NHS National Services Scotland; Edinburgh UK

3. Division of Clinical Pharmacology; Department of Laboratory Medicine; Karolinska Institutet, Karolinska University Hospital Huddinge; Stockholm Sweden

4. Institute for Pharmacological Research ‘Mario Negri’; Milan Italy

5. Prescribing Research Group; University of Liverpool Management School; Liverpool UK

6. WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation; Section of Psychiatry; Department of Public Health and Community Medicine; University of Verona; Verona Italy

7. Department of Medical and Surgical Sciences Pharmacology Unit; Alma Mater Studiorum - University of Bologna; Bologna Italy

8. Centre for Primary Care: Institute of Population Health; University of Manchester; Manchester UK

9. Department of Healthcare Development; Public Healthcare Services Committee Administration, Stockholm County Council; Stockholm Sweden

Publisher

Hindawi Limited

Subject

General Medicine

Reference98 articles.

1. Insight into recent reforms and initiatives in Austria; implications for key stakeholders;Godman;Expert Rev Pharmacoeconomcis Outcomes Res,2008

2. Ongoing pharmaceutical reforms in France; implications for key stakeholder groups;Sermet;Appl Health Econ Health Policy,2010

3. Policies to enhance the efficiency of prescribing in the Spanish Catalan Region: impact and future direction;Coma;Expert Rev Pharmacoecon Outcomes Res,2009

4. Recent national and regional drug reforms in Sweden - implications for pharmaceutical companies in Europe;Wettermark;Pharmacoeconomics,2008

5. Use of generics - a critical cost containment measure for all healthcare professionals in Europe?;Godman;Pharmaceuticals,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence;Journal of Comparative Effectiveness Research;2019-05

2. Ongoing activities to influence the prescribing of proton pump inhibitors within the Scottish National Health Service: their effect and implications;Generics and Biosimilars Initiative Journal;2018-12-15

3. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future;Current Medical Research and Opinion;2018-09-20

4. Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil;Applied Health Economics and Health Policy;2018-07-27

5. Data Resource Profile: The Scottish National Prescribing Information System (PIS);International Journal of Epidemiology;2016-05-10